Evidence map›Paper›PMID 22526604›Full record

ArticleDiabetologia2012

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

S E Inzucchi, R M Bergenstal, J B Buse, M Diamant, E Ferrannini, M Nauck, A L Peters, A Tsapas, R Wender, D R Matthews

Erratum issued 3 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 546 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
546citing papers in PubMed, 16 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03419624 phase3terminatedstarted 2018, after this paper: background citation

A 28-week, Multi-center Randomized, Double-blind, Placebo-controlled Study to Evaluate the Potential of Dapagliflozin Plus Exenatide in Combination With High-dose Intensive Insulin Therapy Compared to Placebo in Obese Insulin-resistant Patients With Type 2 Diabetes Mellitus (Proof-of-concept Study)

Ran2018Enrolled13Registered outcomes7Posted comparisons0ConditionsDiabetes Mellitus, Type 2, ObesityArmsDapagliflozin 10mg, Exenatide 2 mg [Bydureon], Insulin, Metformin, if taken before, Placebo injection
PMID 27651331PMID 18613325PMID 22431673PMID 26213556PMID 25436106PMID 24741511PMID 24251534PMID 22608371PMID 11815510PMID 18165348PMID 20609969PMID 22517736other papers from this trial
Open the trial in the graph
NCT03453970 nacompletednot on this mapstarted 2018, after this paper: background citation

Effectiveness of a Diabetes Education Program Based on Tailored Interventions in the Andalusian Public Health and Social System (Edep-Ti Study).

TypeinterventionalSponsorUniversity of MalagaRan2018 to 2021Enrolled410ConditionsDiabetes Mellitus, Type 2ArmsTherapeutic Education Program
NCT05291026 nacompletednot on this mapstarted 2018, after this paper: background citation

Evaluation of mHealth Intervention to Improve Medication Adherence in Type 2 Diabetes in Nigeria: a Randomized Controlled Trial

TypeinterventionalSponsorObafemi Awolowo UniversityRan2018 to 2019Enrolled120ConditionsDiabetes MellitusArmsmobile phone-based health information
3 · Its place in the literature

Who cites it

546 citing papers in PubMed, 16 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Trial
  20. Trial

486 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors.

S E InzucchiSection of Endocrinology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, CT, USA.
R M Bergenstal
J B Buse
M Diamant
E Ferrannini
M Nauck
A L Peters
A Tsapas
R Wender
D R Matthews

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Disease ManagementEuropeHumansHyperglycemiaHypoglycemic AgentsSocieties, MedicalUnited StatesHypoglycemic Agents

Identifiers

PMID22526604

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.